G.CLIPS biotech

G.CLIPS biotech

Recherche en biotechnologie

ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS

À propos

G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development. G.CLIPS biotech works on solutions in early discovery steps allowing targets to be in a pathology-like format for screening efforts, immunizations and in vitro testing.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
2-10 employés
Siège social
Toulouse
Type
Société indépendante
Fondée en
2020
Domaines
membrane proteins, drug targets, protein stabilisation, in vitro et in cellulo

Lieux

Employés chez G.CLIPS biotech

Nouvelles

Pages similaires

Parcourir les offres d’emploi